Ubergraph |

Ubergraph

Matches in Ubergraph for { ?s <http://purl.obolibrary.org/obo/NCIT_P302> ?o ?g. }

Showing items 1 to 100 of ±756 with 100 items per page.

NCIT_C1005 NCIT_P302 "Myelodysplastic syndrome; multiple myeloma; chronic myeloid leukemia; acute myelocytic leukemia" @default.
NCIT_C1013 NCIT_P302 "Chagas disease" @default.
NCIT_C1014 NCIT_P302 "Photosensitizer, subfoveal choroidal neovascularization" @default.
NCIT_C1016 NCIT_P302 "Dietary supplement; prevention of photosensitivity reactions in patients with erythropoietic protoporphyria; polymorphous light eruption; chemoprevention for cardiovascular disease and cancer" @default.
NCIT_C101790 NCIT_P302 "anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC)" @default.
NCIT_C1023 NCIT_P302 "Various bacterial infections" @default.
NCIT_C102546 NCIT_P302 "multiple myeloma" @default.
NCIT_C102554 NCIT_P302 "metastatic colorectal cancer; metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma" @default.
NCIT_C102566 NCIT_P302 "adult patients with folate receptor alpha (FRα) positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer." @default.
NCIT_C102571 NCIT_P302 "anemia due to chronic kidney disease (CKD); reduction of allogeneic red blood cell transfusions" @default.
NCIT_C102758 NCIT_P302 "B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse; relapsed or refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL) and high grade B-cell lymphoma and DLBCL arising from follicular lymphoma" @default.
NCIT_C102783 NCIT_P302 "patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC); advanced urothelial cancer." @default.
NCIT_C102880 NCIT_P302 "tuberous sclerosis complex (TSC)-associated partial-onset seizures; TSC-associated subependymal giant cell astrocytoma (SEGA) and TSC-associated renal angiomyolipoma" @default.
NCIT_C103147 NCIT_P302 "chronic lymphocytic leukemia (CLL) with 17p deletion and or small lymphocytic lymphoma (SLL)" @default.
NCIT_C103194 NCIT_P302 "locally advanced or metastatic urothelial carcinoma; unresectable stage III non-small cell lung cancer (NSCLC)" @default.
NCIT_C103273 NCIT_P302 "locally advanced or metastatic urothelial carcinoma" @default.
NCIT_C1038 NCIT_P302 "inhalation therapy to produce vasodilation." @default.
NCIT_C104012 NCIT_P302 "treatment of anemia failing an erythropoiesis stimulating agent and requiring 2 or more red blood cell (RBC) units over 8 weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts (MDS-RS) or with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)." @default.
NCIT_C1041 NCIT_P302 "Upper respiratory tract and urinary tract infections; febrile neutropenic conditions" @default.
NCIT_C104153 NCIT_P302 "relapsed or refractory diffuse large B-cell lymphoma (DLBCL)" @default.
NCIT_C104748 NCIT_P302 "non-metastatic castration-resistant prostate cancer" @default.
NCIT_C1054 NCIT_P302 "H. pylori infection; Various bacterial infections" @default.
NCIT_C1057 NCIT_P302 "TdT-positive acute lymphocytic leukemia." @default.
NCIT_C106250 NCIT_P302 "metastatic non-small cell lung cancer (NSCLC); locally advanced or metastatic urothelial carcinoma; extensive-stage small cell lung cancer (ES-SCLC)" @default.
NCIT_C106250 NCIT_P302 "the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression (PD-L1 stained ≥ 50% of tumor cells [TC ≥ 50%] or PD-L1 stained tumor-infiltrating immune cells [IC] covering ≥ 10% of the tumor area [IC ≥ 10%]), with no EGFR or ALK genomic tumor aberrations." @default.
NCIT_C1064 NCIT_P302 "Thrombotic thrombocytopenic purpura; hepatic veno-occlusive disease (VOD)" @default.
NCIT_C106432 NCIT_P302 "postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer; recurrent or metastatic head and neck squamous cell carcinoma (HNSCC); metastatic non-small cell lung cancer (NSCLC) whose tumors express PD-L1; unresectable or metastatic melanoma or melanoma with involvement of lymph node(s) following complete resection; metastatic small cell lung cancer (SCLC); advanced renal cell carcinoma (RCC); recurrent or metastatic cervical cancer; refractory primary mediastinal large B-cell lymphoma (PMBCL); urothelial cancer; hepatocellular carcinoma (HCC); recurrent locally advanced or metastatic Merkel cell carcinoma (MCC)" @default.
NCIT_C106432 NCIT_P302 "soft tissue sarcoma (STS)" @default.
NCIT_C1071 NCIT_P302 "Photosensitizer, bladder, esophagel, gastric, lung and rectal cancer" @default.
NCIT_C1093 NCIT_P302 "Acute leukemia; Adrenal cortical cancer; Brain cancer; Chronic lymphocytic leukemia; Choriocarcinoma; Esophageal cancer; Ewings sarcoma; Gastric cancer; Germ cell cancer; Gestational trophoblastic neoplasms" @default.
NCIT_C1093 NCIT_P302 "Hepatocellular cancer; Hodgkins disease; Hypereosinophilic syndrome; Kaposis sarcoma; Testicular cancer; Thymoma; Thyroid cancer; Uterine cancer; Wilms tumor" @default.
NCIT_C1093 NCIT_P302 "Langerhans cell histiocytosis; Mobilization of peripheral-blood progenitor cells; Multiple myeloma; Neuroblastoma; Non-small lung cancer; Osteogenic sarcoma; Ovarian cancer; Retinoblastoma; Small cell lung cancer; Soft tissue sarcomas" @default.
NCIT_C1094 NCIT_P302 "Acute nonlymphocytic leukemia; Chronic lymphocytic leukemia; Indolent Non - Hodkins Lymphoma" @default.
NCIT_C1097 NCIT_P302 "Estrogen Receptor-Positive Early Breast Cancer; early and advanced-stage breast cancer" @default.
NCIT_C1102 NCIT_P302 "Chronic Lymphocytic Leukemia" @default.
NCIT_C1105 NCIT_P302 "Advanced Prostate Cancer; palliative treatment of breast cancer in postmenopausal women and in men" @default.
NCIT_C1108 NCIT_P302 "Management of Epilepsy; Pain; Mania; Depression and Anxiety Disorders; Postherpetic Neuralgia" @default.
NCIT_C111757 NCIT_P302 "acute lymphoblastic leukemia (ALL)" @default.
NCIT_C1119 NCIT_P302 "Nausea and vomiting prophylaxis, chemotherapy-induced and postoperative" @default.
NCIT_C1126 NCIT_P302 "Haemophilus influenzae B prophylaxis" @default.
NCIT_C11280 NCIT_P302 "None current" @default.
NCIT_C1131 NCIT_P302 "Chemotherapy-induced nausea and vomiting" @default.
NCIT_C113164 NCIT_P302 "adult patients with recurrent or metastatic cervical cancer." @default.
NCIT_C113442 NCIT_P302 "adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy; with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)" @default.
NCIT_C113655 NCIT_P302 "anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC)" @default.
NCIT_C1138 NCIT_P302 "Fungal Infections" @default.
NCIT_C114283 NCIT_P302 "adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements." @default.
NCIT_C114299 NCIT_P302 "adult patients with relapsed or refractory multiple myeloma who have received at least 4 prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent." @default.
NCIT_C114383 NCIT_P302 "newly-diagnosed acute myeloid leukemia (AML) with a susceptible IDH1 mutation" @default.
NCIT_C114498 NCIT_P302 "adult patients with advanced prostate cancer." @default.
NCIT_C114500 NCIT_P302 "adult patients with locally advanced or metastatic urothelial cancer (mUC) who have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting." @default.
NCIT_C1149 NCIT_P302 "Gastritis, gastroesophageal reflux, peptic ulcer disease." @default.
NCIT_C115102 NCIT_P302 "adult patients with myelodysplastic syndromes (MDS)" @default.
NCIT_C115112 NCIT_P302 "metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive" @default.
NCIT_C1153 NCIT_P302 "Nausea and vomiting prophylaxis, chemotherapy-induced and postoperative" @default.
NCIT_C1156 NCIT_P302 "Appetite enhancement, AIDS patients; Breast cancer, palliative treatment; Endometrial carcinoma, palliative treatment" @default.
NCIT_C1160 NCIT_P302 "Gram positive and gram-negative intra-abdominal infections; bacterial meningitis" @default.
NCIT_C116377 NCIT_P302 "metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC)" @default.
NCIT_C116722 NCIT_P302 "relapsed or refractory acute myeloid leukemia (AML)" @default.
NCIT_C116870 NCIT_P302 "locally advanced or metastatic urothelial carcinoma; metastatic Merkel cell carcinoma (MCC); advanced renal cell carcinoma (RCC)." @default.
NCIT_C1170 NCIT_P302 "Skin metastasis of breast cancer" @default.
NCIT_C1172 NCIT_P302 "Anemia of renal insufficiency; Metastatic Breast Cancer" @default.
NCIT_C1173 NCIT_P302 "Prostate cancer" @default.
NCIT_C1176 NCIT_P302 "Ulcerative colitis" @default.
NCIT_C117729 NCIT_P302 "adult patients with multiple myeloma" @default.
NCIT_C1181 NCIT_P302 "Metastatic colorectal cancer; ovarian cancer" @default.
NCIT_C1183 NCIT_P302 "Mesothelioma" @default.
NCIT_C119665 NCIT_P302 "adults with acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation when the disease has come back or has not improved after previous treatment(s)." @default.
NCIT_C119665 NCIT_P302 "relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation" @default.
NCIT_C1200 NCIT_P302 "Acute lymphoblastic leukemia" @default.
NCIT_C120309 NCIT_P302 "for adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy; for adult patients with large B-cell lymphoma (LBCL)." @default.
NCIT_C1212 NCIT_P302 "Kidney transplant rejection, prevention" @default.
NCIT_C121540 NCIT_P302 "metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC" @default.
NCIT_C121553 NCIT_P302 "for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement" @default.
NCIT_C1216 NCIT_P302 "Dietary supplement; vitamin A deficiency" @default.
NCIT_C1217 NCIT_P302 "Dietary supplement; vitamin A deficiency; reduction in falciparum malaria episodes in children older than 12 months old; acne; diminishing malignant cell growth; enhancing the immune system; reduction in mortality of HIV-infected children" @default.
NCIT_C1230 NCIT_P302 "Cisplatin-induced nephrotoxicity; Nitrogen mustard-induced skin toxicity, neutralizer; Poisoning, arsenic and cyanide" @default.
NCIT_C123428 NCIT_P302 "high-risk neuroblastoma in bone or bone marrow" @default.
NCIT_C1238 NCIT_P302 "Palliation of pain in bone metastases" @default.
NCIT_C123827 NCIT_P302 "Treatment of Adults with Unresectable or Metastatic Gastrointestinal Stromal Tumor Harboring a Platelet-derived Growth Factor Receptor Alpha Exon 18 Mutation" @default.
NCIT_C1239 NCIT_P302 "Colonic adenomatous polyps in the inherited disease adenomatous polyposis coli, control and suppression" @default.
NCIT_C124067 NCIT_P302 "adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib." @default.
NCIT_C1244 NCIT_P302 "Malignant glioma (Anaplastic astrocytoma; Anaplastic oligodendrogliomas; Anaplastic oligoastrocytomas; Glioblastoma multiforme); Metastatic melanoma" @default.
NCIT_C124657 NCIT_P302 "paroxysmal nocturnal hemoglobinuria (PNH)" @default.
NCIT_C1247 NCIT_P302 "Male Hypogonadotrophic Hypogonadism; Delayed Puberty-Male and Primary Hypogonadism." @default.
NCIT_C124993 NCIT_P302 "adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations" @default.
NCIT_C125192 NCIT_P302 "adult patients with certain types of large B-cell lymphoma" @default.
NCIT_C125549 NCIT_P302 "adult patients with relapsed or refractory large B-cell lymphoma" @default.
NCIT_C1256 NCIT_P302 "Breast cancer; Desmoid tumors" @default.
NCIT_C1265 NCIT_P302 "Head and neck cancer; Metastatic colorectal adenocarcinoma; Non-small cell lung cancer; Osteogenic sarcoma; Pancreatic adenocarcinoma; Pneumocystitis carinii pneumonia" @default.
NCIT_C1267 NCIT_P302 "Palliative treatment prostate carcinoma" @default.
NCIT_C126799 NCIT_P302 "adult patients with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer" @default.
NCIT_C127012 NCIT_P302 "Emergency Use Authorization (EUA): for the treatment of COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO)." @default.
NCIT_C127119 NCIT_P302 "adult and pediatric patients (12 years and older) with hematologic malignancies" @default.
NCIT_C127123 NCIT_P302 "primary hemophagocytic lymphohistiocytosis (HLH)" @default.
NCIT_C1275 NCIT_P302 "Breast cancer; Cervical cancer; Non-small cell lung cancer; Ovarian cancer; Prostate cancer" @default.
NCIT_C1278 NCIT_P302 "Anxiety; Depression" @default.
NCIT_C1280 NCIT_P302 "Common cold, symptoms; Wound healing; Zinc supplement" @default.
NCIT_C128059 NCIT_P302 "metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation" @default.
NCIT_C1282 NCIT_P302 "Osteogenic sarcoma; CNS and germ cell tumors; ovarian; lung; head and neck; endometrial; esophageal; bladder; breast; cervical cancer." @default.